How does SpA encompass axial and peripheral involvement?

SpA refers to a group of interrelated inflammatory rheumatic diseases that affect both the axial skeleton and peripheral joints, presenting a wide spectrum of clinical manifestations due to its heterogeneous nature. axSpA primarily involves the SI joints and spine, leading to IBP, stiffness, and structural changes such as sacroiliitis and syndesmophyte formation. It is further categorized into nr-axSpA, where radiographic changes are absent, but MRI may show active inflammation and r- axSpA, also known as AS, characterized by visible sacroiliitis on X-rays. MRI has significantly improved early detection before structural damage becomes evident.
In contrast, pSpA is marked by inflammation of peripheral joints, tendon or ligament insertions, and whole digit swelling. Peripheral symptoms may be the predominant clinical feature, particularly in overlap conditions like PsA. Enthesitis is the most frequent peripheral manifestation and can occur alongside arthritis and dactylitis. To classify pSpA, the ASAS developed criteria focusing on patients with predominant peripheral symptoms and minimal or no axial involvement. These criteria include clinical signs like arthritis, enthesitis, or dactylitis, supported by other SpA features such as psoriasis or a history of infection.
Despite differences in presentation, axSpA and pSpA share common underlying immune-inflammatory mechanisms involving genetic markers like HLA-B27 and pro-inflammatory cytokines such as TNF and IL-17. However, variations in cytokine profiles, genetic predispositions, and bone remodeling pathways contribute to the clinical differences between subtypes and may influence treatment choices. Extra- articular features such as AAU, psoriasis, and IBD are frequently associated with SpA and play a critical role in management and prognosis.
The ASAS classification system helps distinguish between axSpA and pSpA based on predominant symptoms, although clinical overlap is common, and many patients present with features of both. While classification criteria are valuable for research and clinical trials, accurate diagnosis and effective management require a holistic clinical assessment that integrates all musculoskeletal and extra- musculoskeletal manifestations.

REFERENCE
1. Poddubnyy D. Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis. Rheumatology (Oxford). 2020 Oct 1;59(Suppl4):iv6-iv17.
2. Akgul O, Ozgocmen S. Classification criteria for spondyloarthropathies. World J Orthop. 2011 Dec
18;2(12):107-15.